Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Canine Arthritis Treatment Market
Canine Arthritis Treatment Market size was valued at USD 2.4 billion in 2023 and is anticipated to register a CAGR of over 4.7% between 2024 and 2032, driven by the growing prevalence of arthritis and related disorders among canines.
Arthritis is one of the most common chronic conditions affecting dogs, particularly as they age or due to genetic predispositions. Factors such as obesity, joint injuries, and certain breeds' susceptibility contribute to the increasing incidence of arthritis in dogs. Additionally, improved awareness and early diagnosis of arthritis by veterinarians and pet owners have led to more dogs receiving treatment for the condition, thereby augmenting the market growth during the analysis period.
Canine arthritis treatment aims to manage pain, reduce inflammation, improve joint function, and enhance the overall quality of life for affected dogs. Treatment options may vary depending on factors such as the severity of the arthritis, the dog's age, breed, size, and overall health condition.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Canine Arthritis Treatment Market Size in 2023: | USD 2.4 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 4.7% |
2024 – 2032 Value Projection: | USD 3.5 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 145 |
Tables, Charts & Figures: | 217 |
Segments covered: | Treatment Type, Arthritis Type, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|